Privat · Selskap · Aksjeselskap

Immunoquest Therapeutics AS

931 892 266 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
AktivRegistrert 2023Lignende selskaper →
Status
â—Ź Aktiv
Stiftet
2023
Omsetning
kr 0
Driftsresultat
kr -2.32M
↳ Brreg · companies

Aktivitetsiste 24 mnd

Ingen stillingsannonseaktivitet registrert
totaler registrert · annonser-over-tid-serie ikke ennå i Intelligo
Registerendringer
Ingen registrerte endringer.
NAV + JobStream · company_hiring · Brreg · company_changes

Tidslinjealle kilder

Audit opinionThe company has resolved not to have the annual accounts audited, so no auditor's report is included. — Selskapet har besluttet at arsreg...Årsrapport · 2025-12-31
Going concernThe notes include a note on uncertainty about going concern, stating that the board has initiated measures to improve equity and liquidit...Årsrapport · 2025-12-31
OwnershipShareholders are Inven2 AS with 60 % (18 000 shares) and The N AS and Jon Amund Kyte with 20 % (6 000 shares) each. — INVEN2 AS The N AS...Årsrapport · 2025-12-31
Share capitalShare capital is NOK 30 000 (30 000 ordinary shares of NOK 1), and an unregistered capital increase of NOK 1 856 693 is recorded in paid-...Årsrapport · 2025-12-31
Related partyShareholder Inven2 AS has provided a loan to the company with an outstanding balance of NOK 1 877 446. — En av selskapets aksjonaerer, In...Årsrapport · 2025-12-31
Loan or financingInterest of NOK 93 508 was charged on the shareholder loan during the year and the loan is unsecured. — regnskapsaret med 93.508. Lanet e...Årsrapport · 2025-12-31
Staff numbersThe company employed 1 full-time equivalent during the financial year. — Antall arsverk sysselsatt i regnskapsaret: 1Årsrapport · 2025-12-31
RemunerationTotal payroll cost was NOK 1 235 533 in 2025 (salary 1 034 721, employer's tax 152 589, other benefits 48 223) against NOK 604 477 in 202...Årsrapport · 2025-12-31
Deferred taxDeferred tax/deferred tax asset is computed on temporary differences; the tax-reducing differences including the loss carryforward of 3 1...Årsrapport · 2025-12-31
OtherThe company conducts medical research and operates from Oslo, and accounting principles were unchanged from 2024 to 2025. — Selskapet dri...Årsrapport · 2025-12-31
THE N AS acquired 20.0 pctNy eier · 2024-12-31
Skiwo · company_events

Stillingsannonser pĂĄ NAV Arbeidsplassen12 MND

Ingen stillingsannonser registrert de siste 12 mĂĄnedene.
NAV Arbeidsplassen · company_job_ad_months

PlasseringOslo

Oslo
kun kommune · gateadresse + koordinater ikke ennå i Intelligo
Brreg · registrert kommune
Er dette ditt selskap? Du kan be om fjerning her